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Summary 
To understand the molecular bases for cytoklne redun- 
dancy and pleiotropy, we have compared the Stat pro- 
teins activated in perlpheml blood lymphocytes (PBLs) 
by cytokines with shared and distinct actlons. interleu- 
kin-2 (IL-2) rapidly activated Stat5 in fresh PBL, and 
Stat2 and Stat5 in pmactivated PBL. IL-7 and IL-15 in- 
duced the same complexes as IL-2, a feature explained 
by the existence of simliar tyrosine-phosphoryiated 
motifs in the cytopiasmic domains of IL-2R5 and IL-7R 
that can serve as docking sites for Stat protelns. IL-13 
induced the same complexes as IL-4, a flnding ex- 
plained by our studies lmplicatlng lL-4R as a shared 
component of the receptors. These studies demon- 
strate that a single cytokine can activate different com- 
binations of Stat proteins under different physloiogical 
conditions, and also indicate two mechanisms by 
which dlstlnct cytokines can activate the same Stat 
protein. 
Introduction 
The term “cytokine pleiotropy” describes the ability of a 
cytokine to exert more than one action, often on multiple 
cell types (Paul, 1969; Leonard, 1994). For example, IL-2 
can induce or augment the cytolytic activity of natural killer 
(NK) cells, the proliferation of Tcells, and immunoglobulin 
biosynthesis by B cells (Leonard et al., 1994; Taniguchi 
and Minami, 1993; Waldmann, 1969). Functional IL-2 re- 
ceptors contain IL-2R6 and the common y chain (Tc) (re- 
viewed by Leonard, 1994; Leonard et al., 1994; Taniguchi 
and Minami, 1993), two cytokine receptor superfamily 
members (Baxan, 1990) whose dimerization is required 
for signaling (Nakamura et al., 1994; Nelson et al., 1994). 
Mutations of the yc gene can result in X-linked severe com- 
bined immunodeficiency (XSCID) in humans (Noguchi et 
al., 1993b); theseverityofthisdisease resultsfromy,being 
a component of the IL-2 (Takeshita et al., 1992), IL4 
(Kondo et al., 1993; Russell et al., 1993), IL-7 (Noguchi 
etal.,1993a;Kondoetal.,1994),IL-9(Russelletal.,1994), 
and IL-15 (Giri et al., 1994) receptors. IL-2,lL4,iL-7,11-g, 
and IL-15can all actasTcell growth factors, therebyexhib 
iting cytokine redundancy, the ability of multiple cytokines 
to induce similar actions(Paul, 1969; Leonard, 1994). 11-2, 
114, IL-7, and IL-9 have been shown to activate two Janus 
family tyrosine kinases, Jakl and Jak3 (Johnston et al., 
1994; Witthuhn et al., 1994; Russell et al., 1994). Jak ki- 
nases play critical signaling roles for interferon (IFN)a@, 
IFNT, and for a number of members of the cytokine recep- 
tor superfamily by activating signal transducers and acti- 
vators of transcription (Stat) proteins (Ihle et al., 1994; 
Darnell et al., 1994). To elucidate the molecular bases of 
cytokine pleiotropy and redundancy, we analyzed the Stat 
proteins activated by a number of cytokines with shared 
and distinct biological activities. 
Results 
Activation of Stat Proteins by IL-2 in Fresh and 
Preactivated PBL and In CTLL-2 Ceils 
We first evaluated the activation of nuclear factors by IL-2 
using electrophoretic mobility shift assays (EMSAs) and 
a probe corresponding to an IFNy-activated site (GAS) 
from the FcqRl gene (core site, 5’-GTAllTCCCAGAAA- 
AGG-3’). IL-2 rapidly induced nuclear binding activity in 
freshly isolated peripheral blood lymphocytes (PBLs) (Fig- 
ure 1 A, lanes 14). When PBLs were preactivated by phy- 
tohemagglutinin (PHA) for 72 hr and then rested overnight, 
little or no binding activity was detected; however, IL-2 
rapidly induced two complexes (Figure 1 A, lanes 5-6) 
the upper component of which had similar mobility to the 
complex induced by IL-2 in M cells (lanes 9-12). The 
complexes induced were specific in that they could be 
competed by cold competitor (data not shown) and were 
not formed with an oligonucleotide containing a single nu- 
cleotide change (TTCCCAQU instead of lTCCCA@IA) 
in the core of the GAS motif (Figure lA, lanes 13-16), 
indicating that the GAS motif is essential for binding and 
therefore suggesting that Stat proteins were involved in 
the formation of the complexes. As expected for Stat pro- 
teins, DNA binding activity was diminished when extracts 
from fresh PBL, preactlvated PBL, or YT cells were treated 
with protein tyrosine phosphatase (Figure 1B). Further- 
more, for both fresh and preactivated PBL, the binding 
activities were induced rapidly in the cytosol, and cyclo- 
heximide did not inhibit the activation of these binding 
activities (data not shown), consistent with the activation 
of preformed cytosolic Stat proteins (Darnell et al., 1994; 
lhleet al., 1994). IL-2alsoactivated Stat proteinsinCTLL-2 
cells (Figure lC, lanes 14) correlating with their vigorous 
IL-Binduced responsiveness. Although rapamycin inhibits 
certain IL-2 signals (Kuo et al., 1992; Morice et al., 1993) 
it did not affect either the activation or nuclear transloca- 
tion of IL-e-activated Stat proteins (data not shown). 
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Figure 1. Rapid Induction of Nuciear Binding Activities by 11-2, IL-f, IL-7, 11-13. and IL-15 
(A) IL-2 rapidly induced nuclear complexes in freshly isolated PBL (lanes l-4), preacttvated PBL (lanes 5-6) and YT cells (lanes 9-12). No 
complexes were detected when the GA6 motif was mutated (lanes 14 and 16 versus lanes 13 and 15). 
(B) Treatment of extracts from fresh PBL (lanes l-5), preactivated PBL (lanes 6-lo), or YT cells (lanes 1 l-16) with 0.1, 0.5. or 1 .O U of T cell 
phosphatase (recombinant human T cell protein tyrosine phosphatase; New England Biolabs) for 39 min at 30% diminished the IL-2activated 
binding activity (lanes 2-4, 7-9, and 12-14) unless inhibited by sodium vanadate (lanes 5, 10, 16-16). 
(C) Stat proteins were activated when CTLM were stimulated with IL-2 for 5-30 min (lanes l-4). 
(0) Induction of nuclear binding activity by IL-2.11-4,11-7, and IL-13 in fresh PBL (lanes l-6) and by IL-2,114, and 11-7, but not IL-13 in preacttvated 
PBL (lanes 6-10). The Fc+tl probe (5’-AGCTTGTATTTCCCAGAAAAGGGATCX’, GAS motif underlined) was used in (A)-(D). 
(E) EMSAs with the IL-2Rf3 (5’-AGCTTGAATTCATGGAMTGGGATC-Y, GAS motif underlined) (lanes l-6) and FcyRl probe (lanes 6-10) using 
IL-2,114, 11-7, or IL-13 activated nuclear extracts derived from fresh PBL. IL-16-induced complexes were compared with IL-2-induced complexes 
in fresh (lanes 11-13) and preactivated (lanes 14-16) PBL. 
Comparison of IL-2-, IL+ IL-7-, IL-M-, 
and IL-154nduced Complexes 
We next compared the Stat proteins activated by IL-2 to 
those activated by IL4 and IL-7, two other T cell growth 
factors known to share ‘yO and activate Jakl and Jak3. 
Whereas IL.2 and IL-7 induced complexes of identical mc- 
bility, IL4 induced a complex with a different appearance 
(Figure 1D). The protein(s) forming the complex(es) in- 
duced by IL4 have been denoted as IL4 NAF (Kotanides 
and Reich, 1993), STF-IL4 (Schindler et al., 1994), and 
IL4 Stat (Hou et al., 1994). IL-13, which shares many ac- 
tions with IL4 (Zurawski et al., 1993; Zurawski and de 
Vries, 1994) induced a complex identical in mobility to 
that induced by IL4, but only in fresh PBL (Figure lD), 
consistent with the inability of IL-13 to stimulate activated 
T cells (Zurawski and de Vries, 1994). The IL-2-, 114, 
IL-7-, and IL-1 3induced complexes were also formed with 
a probe corresponding to a GAS motif found in the IL-2R5 
promoter (Gnarra et at., 1998) (Figure lE, lanes l-lo), a 
gene induced by both IL-2 (Siegel et al., 1987) and IL4 
(Casey et al., 1992). This probe was additionally used to 
demonstrate that IL-1 5 induced complexes indistinguish- 
able from those induced by IL-2 in fresh and preactivated 
PBL (Figure 1 E, lanes 11-18). Interestingly, the IL-2R8 
motif mATG=, -854 to -848 in the coordinate sys- 
tem of Lin et al., 1993; the inverted repeat is underlined) 
was more potent than the FoyRl motif mCCAGM in 
its ability to activate transcription of the TK promoter in 
response to IL-2 in transiently transfected YT cells (data 
not shown). In preactivated PBL stimulated with 11-2, the 
IL-2R8 probe always yielded a single complex (Figure 1 E), 
in contrast with the doublet seen with the FqRl probe 
&I 
C okine Pleiotropy, Redundancy, and Stat Proteins 
A Fresh Preact. B Preact. 
- \L’“- - - + Competitor 
kDa - - -,,- 
69- 
123456 769 
123 4 
1 2 34 5 6 
kDa 
2w- 
97- 
69- 
123 4567 
(Figure 1A); nevertheless, similar ultraviolet (UV) cross- 
linked adducts were seen with the IL-2R6 (see below) and 
FcyRl (data not shown) probes. Thus, fine sequence varia- 
tions within the core and flanking sequences of GAS-like 
sites are critical to cytokine-specific responsiveness. 
UV Cross-Llnklng of IL-2-, IL+ IL-7-, IL-l%, 
and IL-154nduced Complexes 
To analyze further the complexes induced by IL-2, IL-4, 
11-7, 11-13, and 11-15, we used a bromodeoxyuridins 
containing =P-labeled IL-2R6 probe and UV cross-linking 
methodology. As expected, identical patterns were seen 
with extracts from fresh PBL stimulated with 11-2, IL-7, 
or IL-15 (Figure 2A, l-3; Figure 28, lanes 3 and 4); these 
UV cross-linked adducts were specific based on their ab- 
sence in uninduced cells and by their competition by ex- 
cess unlabeled probe (Figure 2A, lanes 7-9). In contrast, 
cellsstimulated with lL4or IL-13yieldedadifferent pattern 
(Figure 28, lanes 5 and 6). For 11-2, IL-7, and IL-15 it was 
striking that the migration of the UV cross-linked adducts 
in preactivated cells differed dramatically from the major 
adduct seen in fresh PBL (Figure 2A, lanes 5 and 6 versus 
2 and 3; Figure 2C, lane 4 versus lane 2). The differences 
between the UV cross-linked adducts in fresh and preacti- 
vated PBL stimulated with IL-4 were much more subtle 
(Figure 2C, lane 3 versus lane 1). Since IL-2 can induce 
Figure 2. UV Cross-Linking Reveals Identity 
of IL-2-, IL-7-, and IL-E-Activated Factors and 
of IL4 and IL-13Activated Factors 
(A) Freshly isolated PBLs were not treated 
(lanes 1,7), or treated with IL-2 (lanes 2,8, S), 
or IL-15 (lane 3), extracts were prepared and 
UV cross-linking was performed. In lane 9,25 
ng of unlabeled probe was added prior to UV 
cross-linking. Preactivated PBLs were not 
treated (lane 4) or treated with IL-2 (lane 5) or 
IL-15 (lane 6) prior to UV cross-finking. 
(B) Preactfvated PBL(lane 1) and YTcells(fane 
2) were stimulated with 11-2. Freshly isolated 
PBL were stimulated with IL-2 (lane 3), IL-7 
(lane 4), IL-4 (lane 5), or IL-13 (lane S), and 
extracts subjected to UV cross-linking using 
the IL-2Rf3 probe. In IL-2-stimulated fresh PBL, 
a primary band of 87.5 kDa and a fainter 96/ 
102.5 kDa doubletwere detected; in IL-Sstimu- 
lated fresh PBL the major band migrated at 85 
kDa, with minor bands of 65 and 102 kDa. 
(C) Comparison of UV cross-linked adducts 
generated using extracts from fresh (lanes 1 
and 2) and preactivated PBL (lanes 3 and 4) 
stimulated with IL-4 (lanes 1 and 3) and IL-7 
(lanes 2 and 4). 
(D) UV cross-linked adducts formed with nu- 
clear extracts from IL-2etimulated purified NK 
cells (lane l), and IL-2-stimulated fresh (lane 
2) or preactivated (lane 3) PBL. UV cross-linked 
adducts formed with nuclear extracts from 
fresh purified T cells not treated (lane 4) or 
treated (lane 5)wlth 11-2, and preactivated puri- 
fied T cells not treated (lane 6) or treated (lane 
7) with 11-2. 
signals in freshly isolated NK cells and T cells (reviewed 
by Leonard and Siegel, 1990) we hypothesized that both 
cell types might contribute to the binding activity induced 
by IL-2 in fresh PBL. Indeed, the major UV cross-linked 
adducts seen in freshly isolated NK and T cells stimulated 
with IL-2 were the same as those seen in fresh PBL stimu- 
lated with IL-2 (Figure 2D, lanes 1, 2, 5), and IL-2-stimu- 
lated preactivated T cells gave the same pattern as did 
preactivated PBL (Figure 2D, lanes 3 and 7). 
Activation by IL-2 of Stat5 In Fresh PBL and Both 
Stst3 and Stat5 In Preactlvated PBL 
We next investigated the identities of the Stat proteins in 
the complex induced by IL-2. Antisera reactive with Stat1 
(both StatlaandStatl6)did not reactwith the IL-2-induced 
complexes (Figure 3A, lanes 2-3,7-6), even though they 
could block formation of the complex induced by IFNa 
(data not shown). However, an antiserum to Stat5 super- 
shifted the complexes induced by IL-2 in both fresh and 
preactivated PBL (Figure 3A, lanes 5 and lo), indicating 
that these complexes contained Stat5 Ovine Stat5 was 
first isolated as a Stat protein activated by prolactin (Wa- 
kao et al., 1994). As expected, the Stat5 antiserum also 
supershifted the complexes induced by IL-7 and 11-15, but 
had no effect on those induced by IL-4 and IL-13 (Figure 
Immunity 
334 
Figure 3. Activation of Stat5 by IL-2,lL-7, and IL-15 in Freshly Isolated 
and Preactivated PBL. and Stat3 by IL-2 Only in Preactivated PBL 
(A) RI 146 anti-Stat5 antiserum supershifted the IL-ainduced com- 
plexes in both fresh and preactivated PBL (lanes 5 and 10). whereas 
antibodies to Stat1 and Statla had no effect. The control preimmune 
serum (pre) is shown for the Stat5 antiserum. 
(B) RI 146 antiserum to Stat5 supershifted the complexes induced by 
11-2, 11-7, and 11-15, but not those induced by IL-4 and IL-13 in fresh 
PBL. 
(C)Anti-phosphotyrosine Western blotting of DNAaffinity-purified wm- 
plexes from fresh (lanes 1 and 2) and preactivated (lanes 3 and 4) 
PBL not stimulated (lanes 1 and 3) or stimulated (lanes 2 and 4) with 
11-2. In fresh PBL. a major band of SO kDa and minor bands of 90 and 
60 kDawere identified. The 60 kDa band in lane 2 was variably detectd 
and could represent a degradation product. For preactivated PBL, 
major and minor bands of 95 and 90 kDa were identified. 
(0) Antiphosphotyrosine (lanes 1 and 2) or anti-Stat5 (lanes 3 and 4) 
Western blotting of DNA affinity-purified complexes from fresh (lanes 
1 and 3) and preactivated (lanes 2 and 4) PBL stimulated with 11-2. 
(E) Ab4 (raised to amino acids 551-507 of Statl), supershifted the 
IL-2-induced complex in preactivated (lane 4) but not in fresh (lane 3) 
PBL. Preimmune serum (pre) had no effect (lanes 1 and 2). 
(F) Lysates from fresh (lanes 1 and 2) and preactivated (lanes 3 and 
4) PBL not stimulated (lane 1 and 3) or stimulated (lanes 2 and 4) 
with IL-2 were immunoprecipitated with 4610 MAb and then Western 
blotted with anti-St@ MAb. 
(G) Anti-Stat3 (lanes 3.4) and anti-Stat5 (lanes 1,.2) Western blotting 
of DNA affinity-purified complexes from preactivated PBL stimulated 
with IL-2 (lanes 1 and 3) or IL-5 (lanes 2 and 4). 
38; data not shown), confirming that these latter cytokines 
induce different complexes. 
To characterize further the IL-2-induced complexes, we 
used DNA affinity purification of IL-Binduced complexes 
followed by Western blotting with antiphosphotyrosine an- 
tibodies (4610) (Figure 3C, lanes 1-4; Figure 3D, lanes 
1 and 2). The relative sizes of the bands identified in fresh 
and preactivated PBL (Figure 3, legend) corresponded to 
those seen by UV cross-linking (see Figure 2; Figure 2, 
legend). The greater apparent molecular weights ob 
served in the UV cross-linking experiments likely result 
from the presence of both protein and the DNA probe in 
the cross-linked adducts. lmmunoblotting of the same af- 
finity-purified material with an anti-Stat5 antiserum (Figure 
3D, lanes 3 and 4) confirmed the presence of Stat5 in 
IL-2-induced complexes in fresh and preactivated PBL. 
The difference in molecular weights seen with fresh and 
preactivated PBL was striking. Although we do not fully 
understand the nature of the difference, it is possible that 
T cell activation induces posttranslational modifications of 
Stat5 Moreover, using a probe based on the cloned ovine 
Stat5 (Wakao et al., 1994), we have isolated three closely 
related human cDNAs, each of which encodes a some- 
what different protein product. Both of the anti-Stat5 anti- 
bodies we have used recognize epitopes present in each 
of these forms of human Stat5, so it is not yet clear whether 
IL-2 activates one or all of the predicted protein products. 
We observed that the complexes induced by IL-2 in fresh 
and preactivated PBLs have different reactivities to an 
antiserum, denoted Ab4, raised to the SH2 domain of Stat1 
(Figure 3E). This antiserum is known to recognize only 
denatured forms of Stat1 and is not capable of supershift- 
ing authentic Stat1 in IFN-induced complexes (Rothman 
et al., 1994). Thus, its ability to supershift the IL-2/IL-7/ 
IL-15 (Figure 3E; data not shown)-induced complexes in 
preactivated PBL is most likely based on cross-reactivity 
with another Stat protein. Since the anti-Stat5 antiserum 
recognized the complexes from both fresh and preacti- 
vated PBL (Figure 3A), while Ab4 recognized only the com- 
plex in preactivated PBL (Figure 3E), we investigated 
whether additional Stat proteins were activated only in 
preactivated PBL. Indeed, we found that IL-2 rapidly acti- 
vated Stat3 in preactivated (Figure 3F, lanes 3 and 4) but 
not in fresh (lanes 1 and 2) PBL. Stat3 was previously 
shown to be activated in response to IL-6 (Akira et al., 
1994) and epidermal growth factor (Zhong et al., 1994). 
By using DNA affinity purification and Western blotting 
with Stat5- and Stat3-specific antisera, we confirmed that 
Stat3 but not Stat5 was present in the IL-6-induced com- 
plex, whereas both Stat3 and Stat5 were in the IL-2-induced 
complex in preactivated PBL (Figure 36). Thus, our data 
support the model that IL-2 activates Stat5 in fresh PBL, 
but both Stat3 and Stat5 in preactivated PBL. So far, we 
have found no evidence that Stat2, Stat4, or IL-4 Stat 
(Stats) are components of the IL-Pinduced complexes in 
either fresh or preactivated PBL. 
Importance of Similar Motlfs In IL-2Rp and IL-7R 
for Stat Protein Bindlng 
The ability of Stat1 to bind to a motif spanning a phosphory- 
lated tyrosine residue in the cytoplasmic domain of the 
IFNy receptor (Greenlund et al., 1994) prompted us to in- 
vestigate whether the binding activity of IL-2-activated Stat 
proteins could be inhibited by peptides spanning phos- 
phorylated tyrosines of IL-2RB or ‘yc. Of the 6 tyrosines in 
human lL-2Rfi, 5 are consenred in mouse and rat. Only 
pY336, pY392, and BY510 were phosphorylated in overex- 
pression experiments in COS-7 cells (M. F. et al., unpub- 
lished data). Tyrosine-phosphorylated peptides spanning 
pY392 or pY510 inhibited nuclear factor binding in extracts 
from fresh PBL, with pY510 being more effective (Figure 
4A). In contrast, pY336, 8Y356 (spanning a tyrosine that 
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does not appear to be phosphorylated in cells), the phos- 
phorylated peptides spanning each rctyrosine, and anon- 
phosphorytated peptide spanning BY510 had no effect 
(Figure 4A). Similar results were found using extracts from 
preactivated PBL, except that only the upper complex was 
eliminated when extracts were preincubated with BY392 
and pY510 (Figure 48). The peptide competitions were 
specific, since phosphorylated BY51 0 did not inhibit forma- 
tion of the nuclear complexes induced by IL4 in fresh and 
preactivated PBL (Figure 4C). BY392 and pY510 exhibited 
sequence similarities (Figure 40). Since IL-7 and IL-2 ap- 
peared to activate the same Stat proteins, we examined 
the sequence of the cloned IL-7 binding protein (IL-7R) for 
a similar motif and found one spanning Y409 (Figure 4D). 
Importantly, a tyrosine-phosphorylated peptide spanning 
IL-7RY409 also inhibited Stat protein binding (Figures 4A 
and 48). 
Interestingly, the IFNyR sequence (TSFGYP04DKPH; 
Greenlund et al., 1994) that binds Stat1 and the lL4R 
sequences (GEXGYP04KXFXXXL; Hou et al., 1994) that 
bind IL4 Stat both contain a lysine C-terminal to the phos- 
phorylated tyrosine; however, no positively charged resi- 
due was present in the IL-2RfML-7R motifs (Figure 4D). 
It will be interesting to determine in detail the sequence 
requirement for receptor-Stat protein association. The im- 
portance of the IL-2R5 motifs was indicated by the dra- 
matic decrease in IL-e-mediated activation of Stat proteins 
in 32D cells transfected with a truncated IL-2Rf3 construct 
in which Y392 and Y510 were deleted as compared with 
cells transfected with wild-type IL-2R5 (Figure 4E). More- 
over, constructs in which all tyrosines except either Y392 
or Y510 were mutated could mediate Stat protein activa- 
tion in response to IL-2 (Figure 4F), indicating that either 
Y392 or Y510 alone was sufficient for this effect. 
Figure 4. The IL-2R5 and IL-7R Cytopfasmic 
Domains Share a Motif Capable of Binding the 
IL-2-Activated Stat Proteins 
Competition of binding of the IL-2-induced 
complexes in fresh (A) and preactivated (8) 
PBL by 5Y392, 5YSlO. and IL-7RY403 tyro- 
sine-phosphorylated peptides but not by un- 
phosphorytated 5Y510. 
(A) 5Y335, 5Y355 and four yc phosphorylated 
peptides did not compete. 
(B) Only the upper complex was competed 
(arrow). 
(C) In fresh and preactlvated PBL, f3Y510 com- 
peted complexes induced by IL-2 (lanes l-4) 
but not by IL-4 (lanes 5-5). 
(0) Alignment of similar residues in the 5Y392, 
5Y510, and IL-7RY409 peptides. 
(2) IL-2 potently induced nuclear complexes in 
32D cells transfected with full-tength IL-2R5 
(Ctani et al., 1 ss2) (lane 4 versus 3) but not in 
cells transfected with the 5-H mutant (lane 8 
versus 5). which is truncated at amino acid 379 
(Hatakeyama et al., IseS). 
(P) Two IL-2R5 constructs in which all tyrosines 
except either Y392 (lanes 3 and 4) or YSIO 
(lanes 5 and 0)were mutated to phenylalanines 
could mediate Stat protein activation in 32D 
cells in response to IL-2 (lanes 4 and 6). 
Role of lL-4R In IL-4- and IL-134sdistsd Signaling: 
Actlvstlon of St&t Proteins by IL-4 and IL-13 
In Cells Lacking rc and Jak3 
Finally, we sought todarify the basis for activation of iden- 
tical Stat proteins by IL4 and IL-13. Based on the ability 
of a nonfunctional IL4 mutant (Yl24D) to block both IL-4 
(Kruse et al., 1992) and IL-13 (Zurawski et al., 1993)action 
it has been concluded that the IL4 and IL-13 receptors 
share a common component (Zurawski et al., 1993). Al- 
though -yc was hypothesized to be this shared component 
(Kondoet al., 1993; Russell et al., 1993) we have not been 
able to confirm this hypothesis (data not shown). Instead, 
our data suggest that the known 140 kDa IL4 binding 
protein (lL4R) itself is the shared component. Of 10 anti- 
lL4R antibodies tested, only those that blocked IL4 action 
also blocked IL-13 action. One of these is shown in Figure 
5A (see also Figure 5A legend). None of the antibodies 
inhibited lL-3-induced proliferation of TF-1 cells (Figure 
5A) nor IL-2/lL-7 actionson IL-2/lL-7-responsive cells (data 
not shown). In contrast with the inhibition of IL-13 action 
by anti-lL4R antibodies, soluble lL4R did not inhibit IL-I 3 
action (Figure 58). This suggests that the lL4R is not the. 
primary binding protein for 11-13. However, the fact that 
both IL4 Y124D (Zurawski et al., 1993) and antibodies to 
lL4R (Figure 5A) inhibit IL-13 action suggests that the 
IL4R is the shared component of the IL4 and IL-13 recep- 
tors. Furthermore, IL4 and IL-13 induced similar nuclear 
complexes in COS-7 cells (Figure 5C) which express lL4R 
but not yc (Russell et al., 1993; data not shown). Addition- 
ally, even though normal human monocytes express yc 
(Bosco et al., 1994; EplingBurnette et al., 1995), two 
monocytic cell lines (THP-1 and Mono Mac 6) lack yc ex- 
pression but nevertheless can respond to IL4 (Takeshita 
et al., 1992; de Wit et al., 1994; Kotanides and Reich, 
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Figure 5. Blocking of IL-I 3 Action by a MAb to the lL4R, and Induction 
of Similar Nudear Complexes by IL4 and IL-13 in Cells Lacking ye 
(A) A MAb to the lL4R (MAb 25452.11; R and D Systems, produced 
using purified recombinant soluble lL4R as an immunogen) inhibited 
IL4 (0.2 @ml)- and IL-13 (6 rig/ml)- but not IL3 (0.3 nglml>induced 
proliferation of TF-1 cells. 0110 MAbs tested, all had concordant ef- 
fects on IL4 and IL-13 (i.e., IL-13 action was inhibited if and only if 
IL4 action was inhibited). One polyclonal antibody and four MAbs 
potently inhibited, four MAbs could inhibit but required approximately 
10,000 higher concentrations, and one MAb did not inhibit at anycon- 
centration tested. 
(6) Soluble IL-OR (O-1000 @ml) inhibited IL4 but not IL-13 action. 
(C) IL4 (lane 2) and IL-13 (lane 3) induced complexes of identical 
mobility in COS7 cells. In (A) and (S), proliferation assays were per- 
formed with TF-1 cells (1 x 1O’cells in 100 ul in each well). Antibodies 
or soluble lL4R were added simultaneously to the cytokines. After a 
2 day incubation, cells were pulsed wtth 0.25 uCiiell of rH)thymidine 
for 2 hr and the incorporated cpm determined. Results were similar 
if TF-1 cells were preincubated with lL4R MAb or soluble lL4R prior 
to addition of cytokine. The ED50s for 11-3, 114, and IL-13 are 0.15 
@ml, 0.1 @ml and 3 @ml, respectively. 
1993). Thus, consistent with an earlier hypothesis that two 
types of IL4 receptors may exist (Rigley et al., 1991), func- 
tional IL4 receptors contain lL4Fl plus either ‘yc (Kondo 
et al., 1993; Russell et al., 1993) or a second protein that 
we shall denote r’ and which we hypothesize may be the 
primary IL-13 binding protein. The existence of y’ is addi- 
tionally suggested by the ability of 1251-lL4 to affinity-label 
a species smaller in molecular weight than the lL4R in 
COS cells (Galizzi et al., 1999). Moreover, the stoichiimetry 
of IL4 binding to lL4R is 1:l (Hoffman et al., 1994), sug- 
gesting the requirement for a second receptor chain to fit 
with the general model that four helix bundle cytokines 
bind to receptors comprising homodimers or heterodimers 
rather than monomeric receptors (Leonard, 1994; Stahl 
and Yancopoulos, 1993; Kishimoto et al., 1994). Although 
both types of IL4 receptors mediate Stat protein activa- 
tion, it is possible that they differ in some of the signals 
transduced; if so, this would represent a mechanism by 
which IL4 can induce different signals (cytokine pleio- 
tropy) according to the type of receptor expressed. 
Dleouselon 
The growth, differentiation, and functional activities of lym- 
phocytes are regulated by the interaction of specific cyto- 
kines with their cell surface receptors. A variety of cyto- 
kines exhibit actions as T cell growth factors; we have 
studied four of these cytokines, IL-2,lL4,lL-7, and IL-15 
all of whose receptors on T cells contain the common y 
chain. In addition, we have studied IL-1 3, a cytokine whose 
receptor does not contain Ye. IL-13 does not stimulate T 
cells, yet it shares actions with IL4 on NK cells and B 
cells. By investigating the Stat proteins activated by these 
cytokines, we have gained insights into some of the mech- 
anisms underlying their shared and distinct actions. 
Previously, IL-2 was shown to induce a nuclear complex 
in a rodent T cell line (Gilmour and Reich, 1994). Interest- 
ingly, the complex exhibited similar mobility with that in- 
duced by prolactin in the same cell line (Gilmour and Reich, 
1994). However, it was not determined whether prolactin 
(which has been shown to activate Stat5 Wakao et al., 
1994) and IL-2 activated the identical Stat proteins. Bead- 
ling et al. (1994) detected an IL-2-activated Stat protein in 
human PBL but did not elucidate its identity. In investigating 
the identity of Stat proteins within IL-2-induced complexes, 
we found that IL-2 can activate different combinations of 
Stat proteins in normal cells under different physiological 
conditions. This has not been reported for any other cyto- 
kine. Based on the difference in UV cross-linked adducts 
in fresh versus preactivated PBL, it was initially surprising 
that the complexes from both fresh and preactffated PBL 
contained Stat5. PHA-mediated posttranslational modifi- 
cations presumably contribute to the size differences 
seen; moreover, the different complexes at least partially 
resulted from the involvement of Stat3 in the preactivated 
complex. 
It remains to be determined whether the complexes 
formed in fresh and preactivated PBL have different func- 
tions: for example, it is conceivable that complexes con- 
taining only Stat5 as are found in freshly isolated cells, 
play a role in augmenting cytolytic activity of NK cells and 
in differentiation of T cells. In contrast, the broader range 
of potential complexes in IL-2-stimulated preactivated PBL 
(i.e., Stat5 and Stat3 homodimers and Stat3-Stat5 hetero- 
dime@, could potentially mediate the triggering of addi- 
tional signals in IL-2-stimulated preactivated PBL, includ- 
ing, for example, its major action in promoting T cell 
proliferation. The induction of distinct complexes in differ- 
ent cell populations may be one mechanism by which cy- 
tokines exert pleiotropic actions. The existence of alterna- 
tive forms of Stat5 may additionally contribute to the 
complexity of IL-2 signals. 
The complexes induced by IL-2 were the same as those 
induced by IL-7 and 11-15, whereas those induced by IL4 
were the same as those induced by 11-13. These observa- 
tions help to explain the basis of cytokine redundancy and 
led us to elucidate how individual Stat proteins can be 
activated by more than one cytokine (Figure 6). Interest- 
C&okine Pleiotropy, Redundancy, and Stat Proteins 
IL-2/1L-7/lL-15 stats 
(Stats- Flesh PBL) 
(stats, StaU- Pmact. PBL) 
Figure 6. Schematic Model Showing that IL-2,lL-7, and IL-15 Activate 
Identical Stat Proteins Due to the Existence of Similar Motifs in IL-2Rl3 
and IL-7R 
IL-4 activates Stat proteins via IL-4 receptors containing lL4R plus Tc 
or lL4R plus y’ (we speculate that y’ is the IL-13R); IL-13 activates 
IL-4 Stat through receptors that appear to contain IL-13R and IL-QR. 
IL-2Rf3 Y392 and Y510 and IL-7R Y409 were identified in this study, 
whereas lL4R Y578 and Y606 were identified by Hou et at. (1994). 
ingly, although the receptors for IL-2,114, and IL-7 share 
Y= and each of these cytokines activate Jakl and Jak3, 
IL-2 and IL-7 activate different Stat proteins than does 114. 
It therefore appears that the primary role of yc is to recruit 
Jak3 (Boussiotis et al., 1994; Russell et al., 1994; Miyazaki 
et al., 1994) while IL-2R6, IL-7R, and lL4R determine 
which Stat protein(s) will be activated. It has been reported 
recently that signaling via receptors that contain “IC can 
prevent the induction of anergy in T cells (Boussiotis et 
al., 1994). It will be interesting to determine the role that 
Stat proteins play in this process. In COS-7 cells, which 
do not express yc or Jak3 (Russell et al., 1993; data not 
shown), the ability of an alternative functional form of the 
IL4 receptor (Figure 6) to mediate Stat protein activation 
represents an additional mechanism for regulating cyto- 
kine-specific signals. 
Thus, we have found that Stat3 and Stat5 can be acti- 
vated by 11-2, IL-7, and IL-15. In addition, we have iden- 
tified two mechanisms by which different cytokines can 
activate the same Stat proteins, either the sharing by re- 
ceptors of a common chain (the IL-2 and IL-15 receptors 
share IL-2Rf3 and the IL4 and IL-13 receptors share IL4R) 
or by distinct receptor chains that share a common motif 
(IL-2R6 and IL-7R). The activation of the same Stat pro- 
teins by distinct cytokines presumably contributes to the 
generation of redundant cytokine actions. In contrast, the 
activation of nonidentical sets of Stat proteins by a single 
cytokine (e.g., the activation of Stat5 in fresh PBL but both 
Stat3 and Stat5 in preactivated PBL) presumably contri- 
butes to cytokine pleiotropy. Importantly, however, IL4 
can act as a T cell growth factor even though it induces 
adifferent complexthandoIL-2, IL-7, and 11-15. It is, there- 
fore, possible that in vivo more than one type (but presum- 
ably not every type) of Stat protein complex can serve to 
activate genes essential to promote T cell proliferation. 
Alternatively, there may be more than one molecular 
mechanism by which T cell growth can be promoted. 
Bxperlmental Procedures 
Cells, Cell Culture, Pmparatlon of Nuclear Extmcts, and EMSAs 
PBLs were isolated from normal donors by standard methods, immedi- 
atelystimulated with cytokines, and nuclear extracts prepared; alterna- 
tively, cells were preactivated by culturing for 72 hr with PHA (1 ug/ml, 
Boehringer-Mannheim) and rested overnight in medium containing 
10% fetal calf serum without 11-2, prior to stimulation with cytokines. 
YT cells were cultured in RPM1 1640 containing 10% fetal calf serum. 
CTLM were cultured in a similar fashion, except that culture was 
supplemented with 5 x IO+ M Pmeroaptoethanol and 20 U/ml 11-2. 
For CTLL-2, cells were grown in the absence of IL-2 for 4 hr prior to 
stimulation with 11-2. Purified NK cells were prepared as described 
by Yamauchl and Bloom (1993). Purified T cells (ranging from 92%- 
96% pure) were isolated by antibody-mediated depletion on magnetic 
beads. Nuclear extracts were prepared as described (Lin et al., 1993) 
and 4 or 10 ug were used in EMSAs. EMSAs were performed as 
previously described (Lin et al., 1993). 
Antlwm 
An anti-human Stat5 antiserum (R1146) was produced by immunizing 
rabbits with a peptide corresponding to amino acids 60-80 of human 
Stat5 (NHrCQELQKKAEHQVGEDG-CCCH; the Cys at the N termi- 
nus was added), synthesized (by G. Poy, National Institutes of Health) 
on an Applied Biosystems 431A peptide synthesizer using a MAP 8 
branched resin (Applied Biisystems). R1146 was used for anti-Stat5 
supershiftand immunoprecipitation experiments. Monoclonal antibod- 
ies (MAbs) to StatP, Stat3, Stat4, and Stat5 were from Transduction 
Laboratories (Lexington, Kentucky). Antisera for p&f@91 (Statl) and 
p91 (Statla) were from Santa Cruz Biotechnology. Monoclonal anti- 
phosphotyrosine antibody 4610 was from Upstate Biotechnology. 
UV CrowLInkIng 
For UV cross-linking experiments, 30-40 ug of nuclear extracts were 
preincubated with 4 pg of poly dl:dC in binding buffer prior to addition 
of 300,000 to 400,000 cpm (1 ng) of probe (the bottom strand of the 
IL-2Rf3 ollgonucleotide, 5’-CATlTCCATGAAlTCGGATCCX’ [this is 
complementary to the strand shown in the Figure 1D legend], was 
labeled by specific priming in the presence of bromodeoxyuridine and 
[yP]dATP). Samples were irradiated for 30 min at 70 W in a Hoefer 
UV cross-linker and resolved on 7.5% SDS gels. For cold competition, 
the unlabeled oligonucleotide was preincubated for 20 min with nu- 
clear extracts prior to addition of probe. 
Atflnlty Purtflcatlon and Weatom Blottlng 
Nuclear extracts (209 pg for 112-stimulated preactivated PBL, 409 pg 
for lL+stimulated preactivated PBL, and 800 pg for IL-2-stimulated 
fresh PBL) were incubated on ice for 15 min in a final volume of 209 
ul binding buffer (12 mM HEPES [pH 7.91.20 mM KCI, 0.5 mM EDTA, 
0.5 mM DlT, 1 mM AEBSF, 10% glycerol) containing 4-16 pg of 
poly dl:dC (Boehringer-Mannheim). Then 40-160 ng of biotinylated 
double-stranded oligonucleotides containing the GAS motifs from IL- 
2RB (S-biotln-GATCGAATTCATGGAAATGGATCGAATTCATGGA- 
MTGGATCGAATTCATGGAAATGC-3) or FcyRl(5’-biotinGATC- 
GTATTTCCCAGAAAAGGATCGTATTTCCCAGAAAAGGATCG- 
TATtlC CCAGAAAATGC-3’) genes (Midland Reagent Company; the 
three copies of the GAS motif in each oligonucleotide are underlined) 
was added and the incubation continued for 15 min at room tempera- 
ture. The reaction was added to streptavidin magnetic beads (Pro- 
mega) that had been washed three times in washing buffer (12 mM 
HEPES ]pH 7.9],109 mM KCI, 1 mM EDTA, 0.5 mM DTT, 12% glycerol, 
1 mM AEBSF, 0.05% NP40, 109 mg/ml bovine serum albumin) and 
incubated for 30 min on ice. The beads were then washed three times 
with washing buffer containing 33 kg/ml poly dl:dC and the bound 
proteins eluted with Laemmli sample buffer, separated on 8% SDS- 
PAGE (Novex), blotted to Immobilon-P membranes, and Western 
analyses performed using either 4610, or with anti-Stat3 or anti- 
Stat5 MAbs, and developed using enhanced chemiluminescence 
(Amersham). 
Immunopreclpitstion and Wsstsm Blotting wlth 
Anti-Phosphotyroslns Antlbodks 
Cells (5-10 x 10s) were stimulated or not stimulated with IL-2 (2 nM), 
washed twice with phosphate-buffered saline, and lysed with 10 mM 
Trfs @H 7.5) containing 2 mM EDTA, 0.15 M NaCI, 0.875% Brij 98, 
0.125% Nonidet P40,0.4 mM NaVO,, 1 mM AEBBF, 2.5 mM leupeptin, 
2.5 mM aprotinin. lmmunoprecipitations were performed using 4610 
MAb and protein A-Sepharoee beads (Pharmacia) at 4OC for 4 hr. 
Samples were washed four times with lysis buffer, and boiled in 2 x 
Laemmli sample buffer. Proteins were analyzed on 8% SDS-PAGE, 
transferred to Immobilon-P membranes, blotted with anti-Stat3 anti- 
body or 4610, and developed with enhanced chemiluminescence. 
Psptlde Competltlon Expsrlments 
Phoephorytated and nonphosphorylated peptides for competition ex- 
periments were synthesized using an Applied Biosystems 431A pep 
tide synthesizer using FMDC chemistry and HBTU activation. FMDC 
phosphotyrosine was from Nova Biochemical. Peptides were purified 
by reverse phase Cl8 high pressure liquid chromatography and quan- 
titated using a PicoTag system (Waters). For the peptide inhibition 
experiments, 109 pM of phosphorylated or nonphosphorylated pep 
tides were preincubated with nuclear extracts for 30 min at room tem- 
perature prior to addition of probe. For BY510 and IL-7RY409, as little 
as 20 pM tyrosine-phosphorylated peptide inhibited binding, whereas 
5Y392 required 100 CM to see complete inhibition. Correctness of 
pepttdes was conftrmed by mass spectroscopy and concentrations 
determined by quantitation with the PicoTag system. 
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